The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Diabetic Patients Polling Results for CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIa Guidelines
1. For patients with UA/NSTEMI and multi vessel disease, CABG with use of the internal mammary arteries can be beneficial over PCI in patients being treated for diabetes mellitus. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIa Recommendation 1 for UA/NSTEMI in Diabetic Patients should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. Percutaneous coronary intervention is reasonable for UA/NSTEMI patients with diabetes mellitus with single-vessel disease and inducible ischemia. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIa Recommendation 2 for UA/NSTEMI in Diabetic Patients should be: CLASS I CLASS IIa CLASS IIb CLASS III

3. In patients with UA/NSTEMI and diabetes mellitus, it is reasonable to administer aggressive insulin therapy to achieve a glucose <150 mg/dL during the first 3 hospital (intensive care unit) days and between 80 and 110 mg/dL thereafter whenever possible. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIa Recommendation 3 for UA/NSTEMI in Diabetic Patients should be: CLASS I CLASS IIa CLASS IIb CLASS III